| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |